Abstract
The WHO definition of health as complete well-being is widely accepted. However, this definition has been criticized as being less feasible for incurable diseases and for the increase in chronic illnesses in ageing societies such as Japan. Therefore, this chapter refers to the alternative concept of health suggested by Huber et al. (2011) as the “ability to adapt and self-manage in the face of social, physical, and emotional challenges”. Accordingly, medical treatment could be interpreted as support for patients to adapt to certain disabilities instead of efforts towards normalization. The cyborg-type robot Hybrid Assistive Limb (HAL) developed by scientist Yoshiyuki Sankai as a device for motor learning is a medical treatment based on this alternative concept. Sankai’s innovation includes the concept of Cybernics, a term coined from cybernetics, mechatronics and informatics. Subsequently, a multi-institutional research group based at Niigata National Hospital in Kashiwazaki City performed a randomized clinical trial (NCY-3001) for gait treatment with HAL in patients with incurable neuromuscular diseases. The clinical trial found that the patients’ subjective evaluations, or patient-reported outcomes (PROs), should be strengthened as evidence of adaptation and improvement of symptoms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
The Orphan Drug Act is a mechanism to support the development of drugs and medical devices for rare diseases with public funds. The act, adopted in the United States in 1983, was established to address the disparity in funding for rare diseases. An almost identical act was adopted in Japan in 1993, in Australia in 1997 and in the EU in 1999.
- 2.
The author himself coordinated the whole clinical trial and functioned as principal investigator of the trial, NCY-3001, registered as JAM-IIA00156.
References
Bagheri, Alireza, Atsushi Asai, and Ryuichi Ida. 2006. Experts’ attitudes towards medical futility: An empirical survey from Japan. BMC Medical Ethics 7 (8/2006): 1–7.
Bernstein, N. 1967. The co-ordination and regulation of movements, 1st, English ed. Oxford: Pergamon Press.
Bobath, Berta. 1970. Adult Hemiplegia: Evaluation and Treatment. London: Heinemann Medical.
Brunnstrom, Signe. 1970. Movement Therapy in Hemiplegia: A Neurophysiological Approach, 1st ed. New York: Medical Dept./Harper & Row.
Carlyle, Thomas. 1999. Sartor Resartus. Oxford: Oxford University Press.
Cella, David, Susan Yount, Nan Rothrock, Richard Gershon, Karon Cook, Bryce Reeve, Deborah Ader, James Fries, Bonnie Bruce, and Mattias Rose. 2007. The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap Cooperative Group During its First Two Years. Medical Care, 45 (5 May 2007), S3-S11. https://doi.org/10.1097/01.mlr.0000258615.42478.55.
Chirico, Francesco. 2016. Spiritual well-being in the 21st century: It is time to review the current WHO’s health definition. JHSS 1 (1): 11–16. https://doi.org/10.19204/2016/sprt2.
Clark, Andy. 2003. Natural-Born Cyborgs: Minds, Technologies, and the Future of Human Intelligence. New York: Oxford University Press.
Cyberdyne. n.d. (a). HAL for Medical Use (Lower Limb Type). Medical European Model (CE 0197). https://www.cyberdyne.jp/english/products/LowerLimb_medical.html. Accessed 26 November 2019.
Cyberdyne. n.d. (b). HAL iryō-yō kashi taipu (JP moderu) [HAL lower limb type for Medical Use]. https://www.cyberdyne.jp/products/LowerLimb_medical_jp.html. Accessed 26 November 2019.
Edelman, Gerald M. 1987. Neural Darwinism: The Theory of Neuronal Group Selection. New York: Basic Books.
Edelman, Gerald. M. 1993. Neural Darwinism: selection and reentrant signaling in higher brain function. Neuron 10 (2): 115–125.
Eisenhauer, Elizabeth A. et al. 2009. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 45 (2), 228–247.
Evans, Scott R. 2010. Fundamentals of clinical trial design. J Exp Stroke Transl Med 3 (1): 19–27.
Faulkner, Alex. 2009. Medical Technology into Healthcare and Society: A Sociology of Devices, Innovation and Governance. New York: Palgrave Macmillan.
Flanders, M. 2009. Voluntary Movement. In Encyclopedia of Neuroscience, ed. Marc Binder, Nobutaka Hirokawa, and Uwe Windhorst, 4371–4375. Berlin, Heidelberg: Springer-Verlag.
Glendinning, Chellis. 1990. Notes towards a Neo-Luddite Manifesto. Utne Reader 38 (Mar/Apr), 50–53.
Grad, Frank P. 2002. The Preamble of the Constitution of the World Health Organization, Bulletin of the World Health Organization 80 (12, 2002), 981–984.
Hebb, Donald. O. 1949. The Organization of Behavior: A Neuropsychological Theory. New York: Wiley.
Hogle, F.Linda. 2008. Emerging Medical Technologies. In The Handbook of Science and Technology Studies, 3rd ed, ed. Edward J. Hackett, Olga Amsterdamska, Michael Lynch, and Judy Wajcman, 841–873. Cambridge, MA: MIT Press.
Huber, Machteld et al. 2011. How Should We Define Health? BMJ 2011 (343, July). https://doi.org/10.1136/bmj.d4163.
ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use). n.d. History. https://www.ich.org/page/history.html. Accessed 8 August 2019.
ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use). 2016. Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2), 9. November. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R2__Step_4_2016_1109.pdf. Accessed 8 August 2019.
Ito, Tatsuya 2016. Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries. PLoS One 11 (2), e0148455.
Kawahira, Kazumi, Tomokazu Noma, Jun`ichi Iiyama, Seiji Etoh, Atsuko Ogata, Megumi Shimodozono. 2009. Improvements in limb kinetic apraxia by repetition of a newly designed facilitation exercise in a patient with corticobasal degeneration. International Journal of Rehabilitation Research 32 (2), 178–183. https://doi.org/10.1097/MRR.0b013e32831e4546.
Knierim, James. 1997. Motor Systems. In: Neuroanatomy Online. Houston: McGovern Medical School, University of Texas. https://nba.uth.tmc.edu/neuroscience/m/s3/index.htm Accessed 26 November 2019.
Knott, Margaret, and Dorothy E. Voss. 1956. Proprioceptive neuromuscular facilitation: patterns and techniques. New York: Hoeber.
Kuntz, Dieter, and Susan D. Bachrach (eds.). 2004. Deadly Medicine: Creating the Master Race. Washington, DC: United States Holocaust Memorial Museum.
Matsuda, Jun. 2012. Enhansumento mondai no ronri-teki / hōteki kentō: Nichi-bei-doku-suisu no hikaku kenkyū [Ethical and Legal Considerations Related to Human Enhancement: A Comparison of the Situations in Japan, Germany, the United States, and Switzerland]. Kenkyū hōkoku-sho [Research Report], Shizuoka University, 15 May. http://hdl.handle.net/10297/6976. Accessed 26 November 2019.
Lock, Margaret. 2008. Biomedical Technologies, Cultural Horizons, and Contested Boundaries. In The Handbook of Science and Technology Studies, 3rd ed, ed. Edward J. Hackett, Olga Amsterdamska, Michael Lynch, and Judy Wajcman, 875–900. Cambridge, MA: MIT Press.
Matsuda, Jun. 2015. Shinkei nanbyō ni okeru kenkō gainen to gendai iryō rinri-gaku [Health Concept in Intractable Neurological Diseases and Modern Medical Ethics]. Sōgō Shinryō [General Practice] 25(3), 258–260.
Nakajima, Takashi. 2011. Clinical trial of robot suit HAL technology for neuromuscular intractable rare diseases. Journal of the National Institute of Public Health 60 (2): 130–137.
Nakajima, Takashi. 2013. Investigator-initiated Clinical Study of Wearable Assistive Robot for Lower Limbs Controlled Voluntarily by Bioelectric Signals etc. (Hybrid Assistive Limb [HAL]-HN01) as a New Medical Device to Delay Progression of Intractable Rare Neuromuscular Diseases-Randomized, Controlled, Crossover Study for Gait Improvement as a Short-Term Effect (Study NCY-3001). Clinical Trials Registry (JMACTR Detail), 26 December. https://dbcentre3.jmacct.med.or.jp/JMACTR/App/JMACTRS06/JMACTRS06.aspx?seqno=3962. Accessed 26 November 2019.
Nakajima, Takashi. 2017a. Assistive technology for supporting communication for patients with incurable and progressive neuromuscular diseases, including transparent character boards, a mouth-shape character method, and an advanced Cybernic Interface device. Journal of the National Institute of Public Health 66 (5): 491–496.
Nakajima, Takashi. 2017b. Cybernic functional regeneration using Hybrid Assistive Limb (HAL) for the patients with neuromuscular and cerebrovascular diseases. Clin. Eval. 45 (2): 352.
Oehrlein, Elisabeth M., Eleanor M. Perfetto, T. Rose Love, Yujin Chung, and Parima Ghafoori. 2018. Patient-Reported Outcome Measures in the Food and Drug Administration Pilot Compendium: Meeting Today’s Standards for Patient Engagement in Development? Value Health 21 (8): 967–972.
PMDA (Pharmaceutical and Medical Device Agency) 2019. Basic concept for Approval and Certification for Medical Devices. http://www.std.pmda.go.jp/scripts/stdDB/pubeng/stdDB_pubeng_regulation.cgi. Accessed 9 August 2019.
President’s Council on Bioethics (US). 2003. Beyond Therapy: Biotechnology and the Pursuit of Happiness. President’s Council on Bioethics (US). http://hdl.handle.net/10822/559341. Accessed 9 August 2019.
Ramón y Cajal, Santiago. 1968 [1928]. Degeneration and regeneration of the nervous system. London, New York: Hafner Publishing Company; Facsimile of the 1928.
Ramón y Cajal, Santiago, Javier DeFelipe, and Edward G. Jones. 1991. Cajal’s Degeneration and Regeneration of the Nervous System. New York: Oxford University Press.
Saraceni, Vincenzo M. 2014. Why evidence-based medicine is an insufficient approach to physical and rehabilitation medicine. Antithesis. Eur J Phys Rehabil Med 50 (5): 593–596.
Sankai, Yoshiyuki. 2010. HAL: Hybrid Assistive Limb Based on Cybernics. Paper presented at the Robotic Research, The 13th International Symposium ISRR.
Sankai, Yoshiyuki, Kenji Suzuki, and Yasuhisa Hasegawa (eds.). 2014. Cybernics: Fusion of human, machine and information systems. Tokyo: Springer Japan.
Schumpeter, Joseph A. 2006 [1912]. Theorie der wirtschaftlichen Entwicklung [Theory of Economic Development]. Berlin: Duncker und Humblot.
Seidler, Rachael D., Jessica A. Bernard, Taritonye B. Burutolu, Brett W. Fling, Mark T. Gordon, Joseph T. Gwin, Youngbin Kwak, and David B. Lipps. 2010. Motor control and ageing: links to age-related brain structural, functional, and biochemical effects. Neuroscience and Biobehavioral Reviews 34 (5): 721–733.
Sprangers, M.A.G., and C.E. Schwartz. 2000. Integrating Response Shift into Health-Related Quality-of-Life Research: A Theoretical Model. In Adaptation to changing health: response shift in quality-of-life research, 1st ed, ed. C.E. Schwartz and M.A.G. Sprangers. Washington, DC: American Psychological Association.
Stevens, Ashley. J., Jonathan J. Jensen, Katrine Wyller, Patrick. C. Kilgore, Sabarni Chatterjee, and Mark L. Rohrbaugh. 2011. The Role of Public-Sector Research in the Discovery of Drugs and Vaccines. The New England Journal of Medicine 364 (6), 535–541. https://doi.org/10.1056/NEJMsa1008268.
Tanno, Kiyomi, Seiji Bito, Yoh Isobe, and Yasuo Takagi. 2016. Validation of a Japanese Version of the Decision Regret Scale. Journal of Nursing Measurement 24 (1): E44–54. https://doi.org/10.1891/1061-3749.24.1.E44.
WHO (World Health Organization). 1995. The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Social Science and Medicine 41 (10): 1403–1409.
Wiener, Norbert. 1954. The human use of human beings: Cybernetics and society. Boston: Houghton Mifflin.
Wiener, Norbert. 1961. Cybernetics: Or Control and Communication in the Animal and the Machine, 2nd ed. New York: MIT Press.
Younger, Jarred, Rebecca McCue, and Sean Mackey. 2009. Pain outcomes: A brief review of instruments and techniques. Current Pain and Headache Reports 13 (1): 39–43.
Zehr, E. Paul, et al. 2016. Neuromechanical interactions between the limbs during human locomotion: An evolutionary perspective with translation to rehabilitation. Experimental Brain Research 234 (11): 3059–3081.
Acknowledgements
I would like to thank Andrew P. Wood for his English-language assistance.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Nakajima, T. (2021). Innovative Technology, Clinical Trials and the Subjective Evaluation of Patients: The Cyborg-type Robot HAL and the Treatment of Functional Regeneration in Patients with Rare Incurable Neuromuscular Diseases in Japan. In: Brucksch, S., Sasaki, K. (eds) Humans and Devices in Medical Contexts. Health, Technology and Society. Palgrave Macmillan, Singapore. https://doi.org/10.1007/978-981-33-6280-2_11
Download citation
DOI: https://doi.org/10.1007/978-981-33-6280-2_11
Published:
Publisher Name: Palgrave Macmillan, Singapore
Print ISBN: 978-981-33-6279-6
Online ISBN: 978-981-33-6280-2
eBook Packages: Social SciencesSocial Sciences (R0)